E-LIB Suche - Ergebnisse für: Galetin, Aleksandra

1

Plasma protein binding in special populations: do current P..:

Al-Qassabi, Jokha ; Tan, Shawn ; Galetin, Aleksandra..
Drug Metabolism and Pharmacokinetics. 55 (2024) - p. 100976 , 2024

Link: https://doi.org/10.1016/..

2

Dealing With Variable Drug Exposure Due to Variable Hepatic..:

Rostami‐Hodjegan, Amin ; Al‐Majdoub, Zubida M. ; von Grabowiecki, Yannick...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

3

In silico modeling and simulation of organ‐on‐a‐chip system..:

Milani, Nicoló ; Parrott, Neil ; Galetin, Aleksandra..
CPT: Pharmacometrics & Systems Pharmacology. 13 (2024) 4 - p. 524-543 , 2024

Link: https://doi.org/10.1002/..

4

Membrane transporters in drug development and as determinan..:

Galetin, Aleksandra ; Brouwer, Kim L. R. ; Tweedie, Donald...
Nature Reviews Drug Discovery. 23 (2024) 4 - p. 255-280 , 2024

Link: https://doi.org/10.1038/..

5

Facing the Facts of Altered Plasma Protein Binding: Do Curr..:

Al-Qassabi, Jokha ; Tan, Shawn Pei Feng ; Phonboon, Patcharapan...
Journal of Pharmaceutical Sciences. 113 (2024) 6 - p. 1664-1673 , 2024

Link: https://doi.org/10.1016/..

6

Bringing totality-of-evidence into PBPK predictions: fracti..:

Izat, Nihan ; Houston, J. Brian ; Barber, Jill..
Drug Metabolism and Pharmacokinetics. 55 (2024) - p. 100953 , 2024

Link: https://doi.org/10.1016/..

7

Database of fraction unbound in plasma (fu) measurements:

Jokha Al-Qassabi ; Shawn Pei Feng Tan ; Patcharapan Phonboon...
doi:10.48420/25243138.v1. , 2024

Link: https://doi.org/10.48420..

8

Database of fraction unbound in plasma (fu) measurements:

Jokha Al-Qassabi ; Shawn Pei Feng Tan ; Patcharapan Phonboon...
doi:10.48420/25243138.v1. , 2024

Link: https://doi.org/10.48420..

9

Development of 4‐Pyridoxic Acid PBPK Model to Support Bioma..:

Tan, Shawn Pei Feng ; Willemin, Marie‐Emilie ; Snoeys, Jan...
Clinical Pharmacology & Therapeutics. 114 (2023) 6 - p. 1243-1253 , 2023

Link: https://doi.org/10.1002/..

10

Use of In Vivo Imaging and Physiologically-Based Kinetic Mo..:

Melillo, Nicola ; Scotcher, Daniel ; Kenna, J. Gerry...
Pharmaceutics. 15 (2023) 3 - p. 896 , 2023

Link: https://doi.org/10.3390/..

11

Estimation of FMO3 Ontogeny by Mechanistic Population Pharm..:

Cleary, Yumi ; Kletzl, Heidemarie ; Grimsey, Paul...
Clinical Pharmacokinetics. 62 (2023) 6 - p. 891-904 , 2023

Link: https://doi.org/10.1007/..

12

Use of In Vivo Imaging and Physiologically-Based Kinetic Mo..:

Melillo, Nicola ; Scotcher, Daniel ; Kenna, J. Gerry...
Melillo , N , Scotcher , D , Kenna , J G , Green , C , Hines , C D G , Laitinen , I , Hockings , P D , Ogungbenro , K , Gunwhy , E R , Sourbron , S , Waterton , J C , Schuetz , G & Galetin , A 2023 , ' Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats ' , Pharmaceutics , vol. 15 , no. 3 , 896 . https://doi.org/10.3390/pharmaceutics15030896. , 2023

Link: https://research.manches..

13

Use of In Vivo Imaging and Physiologically-Based Kinetic Mo..:

Nicola Melillo ; Daniel Scotcher ; J. Gerry Kenna...
Pharmacokinetics and Pharmacodynamics. , 2023

Link: https://doi.org/10.3390/..

14

Use of In Vivo Imaging and Physiologically-Based Kinetic Mo..:

Nicola Melillo ; Daniel Scotcher ; J. Gerry Kenna...
https://www.mdpi.com/1999-4923/15/3/896. , 2023

Link: https://doi.org/10.3390/..

15

Use of In Vivo Imaging and Physiologically-Based Kinetic Mo..:

Melillo, Nicola ; Scotcher, Daniel ; Kenna, J. Gerry...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057977/. , 2023

Link: http://www.ncbi.nlm.nih...